FDA cleared the Allia Moveo from GE Medical Systems SCS on Dec 9, 2025 under K251199, a traditional 510(k). The device falls under product code OWB, Interventional Fluoroscopic X-Ray System, regulated at 21 CFR 892.1650 as a Class 2 device. The review panel was Radiology.

FDA logged the submission as received on Apr 18, 2025. The decision came 235 days later, longer than the 90 FDA-day review goal, which usually means at least one additional information request.

GE Medical Systems SCS has 2 other decisions in the tracker over the last 12 months: K253770 (CardIQ Suite), K260087 (Senographe Pristina; SenoBright HD; Pristina Serena; Pristina Serena Bright).